Digital therapeutics is a rapidly growing field that leverages technology to improve patient outcomes. According to a recent report by Dealroom, the digital therapeutics market is expected to reach $9 billion by 2025, with a compound annual growth rate of 35%. The report highlights several key trends driving the growth of the digital therapeutics market, including increasing adoption of digital tools in healthcare, the growing demand for remote patient monitoring, and the increasing focus on preventative care.
One of the key drivers of the digital therapeutics market is the increasing adoption of digital tools in healthcare. Digital therapeutics can be used to improve patient outcomes by providing targeted, personalized treatment plans and tracking patient progress in real-time. This can help to improve adherence to treatment plans and reduce the risk of complications. Additionally, digital therapeutics can also be used to provide remote patient monitoring, which can help to reduce healthcare costs and improve access to care for patients in remote or underserved areas.
Another key trend driving the growth of the digital therapeutics market is the growing demand for preventative care. Digital therapeutics can be used to help patients manage chronic conditions, such as diabetes or heart disease, by providing education and support to help them make lifestyle changes that can improve their health. This can help to reduce the risk of complications and improve overall patient outcomes. Additionally, digital therapeutics can also be used to provide personalized treatment plans for patients based on their individual needs and risk factors.
Despite the growth in the digital therapeutics market, it is still relatively new and there are many promising startups that are emerging in this space. Here are a few examples:
- Akili Interactive: This digital therapeutics company develops and markets prescription digital therapeutics for children and adults. Their products have been tested in clinical trials and are FDA cleared for the treatment of ADHD and depression.
- Omada Health: Omada Health is a digital therapeutics company that offers a comprehensive digital program to help patients with chronic conditions, such as diabetes and heart disease, manage their health. The program includes a personalized treatment plan, education and support, and remote monitoring.
- Propeller Health: Propeller Health is a digital therapeutics company that focuses on developing products for patients with chronic respiratory conditions, such as asthma and COPD. Their products include a sensor that attaches to a patient’s inhaler and a mobile app that helps patients track their symptoms and medication use.
- WellDoc: WellDoc is a digital therapeutics company that develops products for patients with chronic conditions, such as diabetes and hypertension. Their products include a mobile app that provides personalized treatment plans, education and support, and remote monitoring.
- Livongo: Livongo is a digital therapeutics company that offers a comprehensive digital program to help patients with chronic conditions, such as diabetes and hypertension, manage their health. The program includes a personalized treatment plan, education and support, and remote monitoring.
- iBolit is a digital therapeutics B2B platform for clinics to conduct repeat remote medical consultations. It provides unlimited access for the doctors, while the patients do not need to come to the physical hospital and clinic which allows to provide medical services on a remote basis and enhances medical tourism.
In conclusion, the digital therapeutics market is expected to see significant growth in the coming years, driven by increasing adoption of digital tools in healthcare, growing demand for remote patient monitoring, and increasing focus on preventative care. There are many promising startups in this space, such as Akili Interactive, Omada Health, Propeller Health, WellDoc, and Livongo, that are working to develop innovative digital therapeutics to improve patient outcomes. With the help of technology, digital therapeutics are helping to revolutionize the healthcare industry and improve patient outcomes.